BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37517750)

  • 21. The Effect of
    Hu X; Hong B; Shan X; Cheng Y; Peng D; Hu R; Wang L; Chen W
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of Poria cocos and its components against cisplatin-induced intestinal injury.
    Zou YT; Zhou J; Wu CY; Zhang W; Shen H; Xu JD; Zhang YQ; Long F; Li SL
    J Ethnopharmacol; 2021 Apr; 269():113722. PubMed ID: 33352240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Calcium Oxalate Formation and Antioxidant Activity of Carboxymethylated
    Li CY; Liu L; Zhao YW; Chen JY; Sun XY; Ouyang JM
    Oxid Med Cell Longev; 2021; 2021():6653593. PubMed ID: 33747347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulatory effects exerted by Poria Cocos polysaccharides via TLR4/TRAF6/NF-κB signaling in vitro and in vivo.
    Tian H; Liu Z; Pu Y; Bao Y
    Biomed Pharmacother; 2019 Apr; 112():108709. PubMed ID: 30970514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota.
    Sun SS; Wang K; Ma K; Bao L; Liu HW
    Chin J Nat Med; 2019 Jan; 17(1):3-14. PubMed ID: 30704621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunomodulatory effect of Poria cocos polysaccharides is mediated by the Ca
    Pu Y; Liu Z; Tian H; Bao Y
    Int Immunopharmacol; 2019 Jul; 72():252-257. PubMed ID: 31003002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihepatotoxic benefits of Poria cocos polysaccharides on acetaminophen-lesioned livers in vivo and in vitro.
    Wu K; Guo C; Yang B; Wu X; Wang W
    J Cell Biochem; 2019 May; 120(5):7482-7488. PubMed ID: 30378160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoprotective effects exerted by Poria Cocos polysaccharides against acetaminophen-induced liver injury in mice.
    Wu K; Fan J; Huang X; Wu X; Guo C
    Int J Biol Macromol; 2018 Jul; 114():137-142. PubMed ID: 29572139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning of a Poria cocos protein that activates Th1 immune response and allays Th2 cytokine and IgE production in a murine atopic dermatitis model.
    Lu YT; Kuan YC; Chang HH; Sheu F
    J Agric Food Chem; 2014 Apr; 62(13):2861-71. PubMed ID: 24625278
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Zhou X; Wang J; Zhou S
    Aging (Albany NY); 2024 Mar; 16(7):6147-6162. PubMed ID: 38507458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel immunomodulatory protein from Poria cocos induces Toll-like receptor 4-dependent activation within mouse peritoneal macrophages.
    Chang HH; Yeh CH; Sheu F
    J Agric Food Chem; 2009 Jul; 57(14):6129-39. PubMed ID: 19548679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poria cocos polysaccharide induced Th1-type immune responses to ovalbumin in mice.
    Dong X; Li B; Yu B; Chen T; Hu Q; Peng B; Sheng W
    PLoS One; 2021; 16(1):e0245207. PubMed ID: 33411807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polysaccharide PCP-I isolated from
    Liu K; Yin Y; Zhang J; Zai X; Li R; Ma H; Xu J; Shan J; Chen W
    Hum Vaccin Immunother; 2020 Jul; 16(7):1699-1707. PubMed ID: 31809637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Structural characterization of PCP-Ⅰ from Poria as vaccine adjuvant and its hydrolytic oligosaccharide].
    Gu JN; Liu GX; Li S; Ma H; Shan JJ
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4429-4437. PubMed ID: 37802869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural identification of a fucose-containing 1,3-β-mannoglucan from Poria cocos and its anti-lung cancer CL1-5 cells migration via inhibition of TGFβR-mediated signaling.
    Lin TY; Lu MK; Chang CC
    Int J Biol Macromol; 2020 Aug; 157():311-318. PubMed ID: 32302633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poria cocos polysaccharides exert prebiotic function to attenuate the adverse effects and improve the therapeutic outcome of 5-FU in Apc
    Yin L; Huang G; Khan I; Su L; Xia W; Law BYK; Wong VKW; Wu Q; Wang J; Leong WK; Hsiao WLW
    Chin Med; 2022 Oct; 17(1):116. PubMed ID: 36192796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poria cocos polysaccharide attenuates RANKL-induced osteoclastogenesis by suppressing NFATc1 activity and phosphorylation of ERK and STAT3.
    Song D; Cao Z; Tickner J; Qiu H; Wang C; Chen K; Wang Z; Guo C; Dong S; Xu J
    Arch Biochem Biophys; 2018 Jun; 647():76-83. PubMed ID: 29678628
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Zhang DD; Li HJ; Zhang HR; Ye XC
    Food Funct; 2022 Jun; 13(12):6648-6664. PubMed ID: 35642970
    [No Abstract]   [Full Text] [Related]  

  • 39. Qualitative and quantitative characterization of carbohydrate profiles in three different parts of Poria cocos.
    Zhu L; Wang X; Li S; Qi ER; Meng J; Ching Lam KY; Dong X; Xu J; Chen H; Zhao Z
    J Pharm Biomed Anal; 2020 Feb; 179():113009. PubMed ID: 31816475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant activity of PCP-II, a polysaccharide from Poria cocos, on a whole killed rabies vaccine.
    Zhang W; Cheng N; Wang Y; Zheng X; Zhao Y; Wang H; Wang C; Han Q; Gao Y; Shan J; Yang S; Xia X
    Virus Res; 2019 Sep; 270():197638. PubMed ID: 31173772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.